77 related articles for article (PubMed ID: 21559700)
1. Lack of correlation between defective cell-mediated-immunity and levels of secreted or circulating cytokines in a study of 90 cancer-patients.
Mantovani G; Maccio A; Esu S; Lai P; Ghiani M; Turnu E; Contu G; Volpe A; Delgiacco G
Int J Oncol; 1994 Dec; 5(6):1211-7. PubMed ID: 21559700
[TBL] [Abstract][Full Text] [Related]
2. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.
Mantovani G; Macciò A; Lai P; Ghiani M; Turnu E; Del Giacco GS
Cell Biophys; 1995 Aug; 27(1):1-14. PubMed ID: 7493395
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection.
Ward BJ; Johnson RT; Vaisberg A; Jauregui E; Griffin DE
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):236-48. PubMed ID: 1914259
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.
Mantovani G; Macciò A; Astara G; Contini L; Esu S; Littera S; Arangino V; Lai P; Proto E; Pusceddu G
Cell Biophys; 1993; 22(1-3):79-99. PubMed ID: 7889544
[TBL] [Abstract][Full Text] [Related]
7. Effects of hCG and beta-hCG on IL-2 and sIL-2R secretion from human peripheral blood mononuclear cells: a dose-response study in vitro.
Komorowski J; Gradowski G; Stepień H
Immunol Lett; 1997 Oct; 59(1):29-33. PubMed ID: 9334854
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
9. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
[TBL] [Abstract][Full Text] [Related]
10. [p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors].
Mantovani G; Macciò A; Contini L; Esu S; Littera S; Lai P; Proto E; Balestrieri A; Del Giacco GS
Recenti Prog Med; 1993 Jun; 84(6):415-22. PubMed ID: 8516548
[TBL] [Abstract][Full Text] [Related]
11. In vitro production of TNF-alpha,IL-6 and sIL-2R in Chinese patients with ulcerative colitis.
Xia B; Guo HJ; Crusius J; Deng CS; Meuwissen S; Pena A
World J Gastroenterol; 1998 Jun; 4(3):252-255. PubMed ID: 11819289
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
13. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
14. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
15. Increased production of tumor necrosis factor-alpha and release of soluble CD4 and CD8 molecules, but decreased responsiveness to phytohemagglutinin in patients with nasopharyngeal carcinoma.
Kuo WR; Yu HS; Chang KL; Juan KH; Jan YS; Yu CL
J Formos Med Assoc; 1994 Jul; 93(7):569-75. PubMed ID: 7866054
[TBL] [Abstract][Full Text] [Related]
16. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
17. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
18. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
Vine JB; Geppert TD; Lipsky PE
J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
20. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
